Novartis Amgen

Showing 2 posts of 2 posts found.

amgen_flag

Court sides with Amgen in Sandoz’ challenge over patent on Enbrel

August 12, 2019
Sales and Marketing Enbrel, IP, Novartis Amgen, court, patent, pharma

A US court has sided with Amgen in a legal battle over the patent on blockbuster rheumatoid arthritis drug Enbrel. …

headache

Novartis’ Phase 3 migraine data could revolutionise treatment

November 30, 2017
Research and Development CGRP, Novartis Amgen, biotech, drugs, migraine, pharma, pharmaceutical

Descriptions of treatments as ‘revolutionary’ or ‘ground-breaking’ are ten a penny in the pharmaceutical industry, very rarely do such treatments …

Latest content